Biotechnology Market: Current Analysis and Forecast (2021-2027)

Report Description

Biotechnology Market was valued at US$ 700 billion in 2020 and is expected to grow at a CAGR of 13% over the forecast period (2021-2027). The growth of the biotechnology sector in developing countries like India and China, there market is being driven by favorable government initiatives. Government activities are aimed at modernizing the medication regulatory system, standardizing clinical trials, enhancing reimbursement rules, and expediting the product approval process, all of which promise attractive development potential. Small molecules dominated the pharmaceutical compounds pipeline with around 22 U.S. FDA approvals as compared to eight large molecules (biotech). Around 4 out of every 10 drugs are biotech derived, which can be attributed to the growing demand for orphan drugs and personalized medicine. Moreover, agricultural companies are concentrating their efforts on bringing agricultural innovations to market to boost production through long-term solutions. For example, BASF said in February 2020 that by 2029, it will have launched more than 30 initiatives aimed at producing novel seeds, traits, biological and chemical crop protection solutions, new formulations, and digital products.

  REQUEST FREE SAMPLE PDF 

The demand for novel gene therapies, including DNA sequencing for better treatment outcomes, will increase as the patient pool with chronic diseases grows. Furthermore, the rising prevalence of chronic illnesses is due to an increase in the consumption of bad diets, as well as lifestyle choices such as alcohol drinking and tobacco smoking. According to the WHO’s 2018 report, cancer was the second biggest cause of death worldwide in 2018, with 9.6 million deaths estimated. The industry will develop thanks to a wide range of uses and rising demand for vaccinations and efficient treatments. Furthermore, increasing R&D spending for biotechnology developments and boosting healthcare access in places with unmet medical requirements would boost revenue.

Top Selling Biotech Drugs Worldwide, (USD Bn)

Abbott Laboratories, Amgen, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Illumina, Merck, PerkinElmer, Qiagen, and Thermo Fisher Scientific are some of the prominent players operating in the global Biotechnology market. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.

Insights Presented in the Report

“Amongst Technology, Nanobiotechnology segment holds the major share”

Based on the technology, the market is fragmented nanobiotechnology, tissue engineering & regeneration, DNA sequencing, cell-based assays, fermentation, PCR technology, chromatography, and others. The nanotechnology segment dominated the market with a share of XX% in 2020 and is expected to maintain its dominance during the forecast period owing to the continuous advancements and wide range of applications.

“Amongst Application, Bio-Agriculture segment is anticipated to grow at the highest CAGR during the analyzed period”

Further based on application, the market is fragmented into bio-pharmacy, bio-services, bio-agriculture, bio-industrial, and bioinformatics. In 2020, bio-agriculture accounted for a maximum market revenue share of XX% and is expected to remain dominant during the analyzed period.

“North America signifies one of the largest markets of Biotechnology Market”

For a better understanding of the market dynamics of the Biotechnology market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX billion in 2020 growing number of businesses operating in the region are gaining drug approvals, which is fueling market expansion. For instance, in February 2021, Biogen Inc. received the U.S. FDA for PLEGRIDY (peginterferon beta-1a) that is used for the treatment of relapsing forms of multiple sclerosis. The approval expands the company’s leading portfolio for multiple sclerosis treatment. However, the Asia Pacific region would grow at the highest rate during the forecast period.

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry

Customization Options:

Biotechnology Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Research Methodology

Analyzing the historical market, estimation of the current market, and forecasting the future market of the Global Biotechnology Market were the three major steps undertaken to create and analyze the adoption of Biotechnology for the different diseases across major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the Biotechnology sector. Post assumption and validation of market numbers through primary interviews, we employed a top-down/ bottom-up approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detailed secondary study was conducted to obtain the historical market size of the Biotechnology through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the Biotechnology market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments for major regions. Major segments included in the report are technology and application. Further country-level analyses were conducted to evaluate the overall adoption of Biotechnology in every region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of Biotechnology. Further, we conducted factor analysis using dependent and independent variables such as increasing chronic disease incidences and growing geriatric population. A thorough analysis was conducted for demand and supply-side scenario considering top partnerships, merger and acquisition, business expansion, and product launches in the Biotechnology industry across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Biotechnology market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e. top-down approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

• The industry’s market size, in terms of value (USD) and the adoption rate of Biotechnology across the major markets domestically
• All percentage shares, splits, and breakdowns of market segments and sub-segments
• Key players in the Biotechnology market in terms of services offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the Biotechnology market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of the technology and application end-user of the Biotechnology market.

Main Objective of the Biotechnology Market Study

The current & future market trends of Biotechnology were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

• Analyze the current and forecast market size of Biotechnology in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
• Segments in the study include areas of application and technology
• Define and analysis of the regulatory framework for the Biotechnology industry
• Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
• Analyze the current and forecast market size of the Biotechnology market for the major region
• Major regions studied in the report include North America (the United States and Canada), Europe (Germany, France, Italy, Spain, and United Kingdom), Asia-Pacific (China, Japan, India, and Australia), and Rest of the World
• Company profiles of the Biotechnology market and the growth strategies adopted by the market players to sustain in the fast-growing market
• Deep dive regional level analysis of the industry